Gujarat Inject Kerala Ltd
Fundamental Score
Gujarat Inject Kerala Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of GUJINJEC across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Excellent EPS Growth (104.89% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
10 factors identified
Margin Pressure Concerns (2.32%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Premium Valuation Risk (P/E: 98.61x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Profit Decline Concern (-88.52%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.
Revenue Contraction (-81.65%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.
Negative Free Cash Flow (₹-9.61 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Low Promoter Commitment (0.00%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Gujarat Inject Kerala Ltd
About GUJINJEC
Business Overview
Gujarat Inject (Kerala) Limited engages in the business of trading of goods. Gujarat Inject (Kerala) Limited was incorporated in 1991 and is based in Vadodara, India.
Company Details
Key Leadership
GUJINJEC Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Gujarat Inject Kerala Ltd (GUJINJEC)?
As of 30 Jan 2026, 01:38 pm IST, Gujarat Inject Kerala Ltd (GUJINJEC) is currently trading at ₹48.69. The stock has a market capitalization of ₹41.42 (Cr).
Is GUJINJEC share price Overvalued or Undervalued?
GUJINJEC is currently trading at a P/E ratio of 98.61x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Gujarat Inject Kerala Ltd share price?
Key factors influencing GUJINJEC's price include its quarterly earnings growth (Sales Growth: -81.65%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Gujarat Inject Kerala Ltd a good stock for long-term investment?
Gujarat Inject Kerala Ltd shows a 5-year Profit Growth of N/A% and an ROE of 11.00%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.
How does Gujarat Inject Kerala Ltd compare with its industry peers?
Gujarat Inject Kerala Ltd competes with major peers in the Pharmaceuticals. Investors should compare GUJINJEC's P/E of 98.61x and ROE of 11.00% against the industry averages to determine its competitive standing.
What is the P/E ratio of GUJINJEC and what does it mean?
GUJINJEC has a P/E ratio of 98.61x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹99 for every ₹1 of annual earnings.
How is GUJINJEC performing according to Bull Run's analysis?
GUJINJEC has a Bull Run fundamental score of 12.1/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does GUJINJEC belong to?
GUJINJEC operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Gujarat Inject Kerala Ltd.
What is Return on Equity (ROE) and why is it important for GUJINJEC?
GUJINJEC has an ROE of 11.00%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Gujarat Inject Kerala Ltd generates profits from shareholders' equity.
How is GUJINJEC's debt-to-equity ratio and what does it indicate?
GUJINJEC has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is GUJINJEC's dividend yield and is it a good dividend stock?
GUJINJEC offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has GUJINJEC grown over the past 5 years?
GUJINJEC has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth 104.89%.
What is the promoter holding in GUJINJEC and why does it matter?
Promoters hold 0.00% of GUJINJEC shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is GUJINJEC's market capitalization category?
GUJINJEC has a market capitalization of ₹41 crores, placing it in the Small-cap category.
How volatile is GUJINJEC stock?
GUJINJEC has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for GUJINJEC?
GUJINJEC has a 52-week high of ₹N/A and low of ₹N/A.
What is GUJINJEC's operating profit margin trend?
GUJINJEC has a 5-year average Operating Profit Margin (OPM) of 2.32%, indicating the company's operational efficiency.
How is GUJINJEC's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of -81.65% and YoY Profit Growth of -88.52%.
What is the institutional holding pattern in GUJINJEC?
GUJINJEC has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.